CULTURED AFB ANTITUBERCULAR DST RAPID 10 DRUGS PANEL Test
Test Cost: AED 2690.0
Are you experiencing symptoms of tuberculosis? Are you looking for an accurate diagnosis? DNA Labs UAE offers the Cultured AFB Antitubercular DST Rapid 10 Drugs Panel Test at an affordable price of AED 2690.0.
Test Components:
- Streptomycin
- Isoniazid
- Rifampicin
- Ethambutol
- Pyrazinamide
- Clofazimine
- Ethionamide
- Capreomycin
- Kanamycin
- Amikacin
Sample Condition: To conduct the test, please submit a pure growth of Mycobacterium tuberculosis complex on appropriate media in a sterile screw-capped container, sealed in a plastic bag, and ship refrigerated. If you have already submitted specimens for AFB culture or Mycobacteria identification tests, the pure growth obtained in the laboratory will be processed for Antitubercular Sensitivity.
Report Delivery: The test report will be delivered daily by 3.30 pm. Please note that the report will take 21 days to be processed.
Method: The Cultured AFB Antitubercular DST Rapid 10 Drugs Panel Test is performed using an automated fluorescent method.
Test Type: This test specifically targets tuberculosis infections.
Doctor: The test will be conducted under the supervision of a physician.
Test Department: This test is conducted in our specialized Test Department.
Pre Test Information:
No special preparation is required before taking this test.
Test Details:
The Cultured AFB Antitubercular DST Rapid 10 Drugs Panel Test is a diagnostic test used to determine the susceptibility of mycobacterial strains to various antitubercular drugs. It is primarily used for detecting drug resistance in tuberculosis (TB) infections.
The test involves culturing the mycobacterial strain in a laboratory setting and exposing it to a panel of ten different antitubercular drugs. These drugs include isoniazid, rifampicin, ethambutol, streptomycin, pyrazinamide, kanamycin, amikacin, capreomycin, ofloxacin, and moxifloxacin.
By monitoring the growth of the bacteria in the presence of these drugs, the test can determine whether the strain is susceptible or resistant to each drug. This information is crucial for guiding the appropriate treatment regimen for TB patients, as drug-resistant strains require different medications and longer treatment durations.
Overall, the Cultured AFB Antitubercular DST Rapid 10 Drugs Panel Test helps healthcare providers make informed decisions regarding the management of TB infections and helps prevent the development of further drug resistance.
Test Name | CULTURED AFB ANTITUBERCULAR DST RAPID 10 DRUGS PANEL Test |
---|---|
Components | *Streptomycin*Isoniazid*Rifampicin *Ethambutol*Pyrazinamide *Clofazimine *Ethionamide*Capreomycin*Kanamycin *Amikacin |
Price | 2690.0 AED |
Sample Condition | Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated ORwhen used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity. |
Report Delivery | Sample Daily by 3.30 pm; Report 21 days |
Method | Automated Fluorescent |
Test type | Tuberculosis |
Doctor | Physician |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details |
The Cultured AFB Antitubercular DST Rapid 10 Drugs Panel Test is a diagnostic test used to determine the susceptibility of mycobacterial strains to various antitubercular drugs. It is primarily used for detecting drug resistance in tuberculosis (TB) infections. The test involves culturing the mycobacterial strain in a laboratory setting and exposing it to a panel of ten different antitubercular drugs. These drugs include isoniazid, rifampicin, ethambutol, streptomycin, pyrazinamide, kanamycin, amikacin, capreomycin, ofloxacin, and moxifloxacin. By monitoring the growth of the bacteria in the presence of these drugs, the test can determine whether the strain is susceptible or resistant to each drug. This information is crucial for guiding the appropriate treatment regimen for TB patients, as drug-resistant strains require different medications and longer treatment durations. Overall, the Cultured AFB Antitubercular DST Rapid 10 Drugs Panel Test helps healthcare providers make informed decisions regarding the management of TB infections and helps prevent the development of further drug resistance. |